1. Home
  2. NRXP vs HLP Comparison

NRXP vs HLP Comparison

Compare NRXP & HLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • HLP
  • Stock Information
  • Founded
  • NRXP 2015
  • HLP 2021
  • Country
  • NRXP United States
  • HLP China
  • Employees
  • NRXP N/A
  • HLP N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • HLP Industrial Machinery/Components
  • Sector
  • NRXP Health Care
  • HLP Industrials
  • Exchange
  • NRXP Nasdaq
  • HLP Nasdaq
  • Market Cap
  • NRXP 14.8M
  • HLP 15.5M
  • IPO Year
  • NRXP N/A
  • HLP 2023
  • Fundamental
  • Price
  • NRXP $1.16
  • HLP $1.20
  • Analyst Decision
  • NRXP Strong Buy
  • HLP
  • Analyst Count
  • NRXP 3
  • HLP 0
  • Target Price
  • NRXP $31.33
  • HLP N/A
  • AVG Volume (30 Days)
  • NRXP 153.3K
  • HLP 12.2K
  • Earning Date
  • NRXP 11-18-2024
  • HLP 11-26-2024
  • Dividend Yield
  • NRXP N/A
  • HLP N/A
  • EPS Growth
  • NRXP N/A
  • HLP N/A
  • EPS
  • NRXP N/A
  • HLP N/A
  • Revenue
  • NRXP N/A
  • HLP $14,045,084.00
  • Revenue This Year
  • NRXP N/A
  • HLP N/A
  • Revenue Next Year
  • NRXP N/A
  • HLP N/A
  • P/E Ratio
  • NRXP N/A
  • HLP N/A
  • Revenue Growth
  • NRXP N/A
  • HLP N/A
  • 52 Week Low
  • NRXP $1.10
  • HLP $0.72
  • 52 Week High
  • NRXP $7.33
  • HLP $5.54
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 33.72
  • HLP 44.73
  • Support Level
  • NRXP $1.23
  • HLP $1.18
  • Resistance Level
  • NRXP $1.30
  • HLP $1.31
  • Average True Range (ATR)
  • NRXP 0.10
  • HLP 0.08
  • MACD
  • NRXP 0.00
  • HLP 0.02
  • Stochastic Oscillator
  • NRXP 12.12
  • HLP 41.50

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About HLP Hongli Group Inc.

Hongli Group Inc is a cold roll formed steel profile manufacturer in China. It customizes and manufactures cold roll formed steel profiles for machinery and equipment in a variety of sectors, including but not limited to mining and excavation, construction, agriculture and transportation.

Share on Social Networks: